Lördag 23 November | 17:52:26 Europe / Stockholm

Kalender

Tid*
2025-06-25 - Årsstämma
2025-03-05 06:00 Bokslutskommuniké 2024
2024-11-27 06:00 Kvartalsrapport 2024-Q3
2024-09-12 - Extra Bolagsstämma 2024
2024-09-12 - Kvartalsrapport 2024-Q2
2024-06-28 - Kvartalsrapport 2024-Q1
2024-06-27 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2024-06-26 - Årsstämma
2024-03-20 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-09-26 - Kvartalsrapport 2023-Q2
2023-06-21 - Årsstämma
2023-06-21 - Kvartalsrapport 2023-Q1
2023-03-30 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2023-02-17 - Bokslutskommuniké 2022
2022-12-09 - Extra Bolagsstämma 2022
2022-10-26 - Kvartalsrapport 2022-Q3
2022-08-15 - Kvartalsrapport 2022-Q2
2022-04-28 - Kvartalsrapport 2022-Q1
2022-04-19 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 - Årsstämma
2022-02-16 - Bokslutskommuniké 2021
2021-12-29 - Extra Bolagsstämma 2021
2021-11-17 - Kvartalsrapport 2021-Q3
2021-09-08 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-04-14 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 - Årsstämma
2021-02-09 - Bokslutskommuniké 2020
2020-12-14 - Kvartalsrapport 2020-Q3
2020-09-30 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 - Årsstämma
2020-06-30 - Kvartalsrapport 2020-Q1
2019-12-20 - Extra Bolagsstämma 2019
2019-06-27 - Årsstämma
2019-06-03 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 - Split SOFTX 1:50

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo, Norge.
2024-07-23 14:16:23
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES (OR ANY OTHER
JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL). THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.

Reference is made to the stock exchange announcement published by Softox
Solutions AS (the "Company") on 17th July 2024 with key information relating to
the preferential rights issue in the Company (the "Rights Issue"). Please see
updated key information relating to the Rights Issue included below.

Date on which the terms and conditions of the preferential rights issue were
announced: On or about 17th of July 2024

Last day including right: 31st of July 2024

Ex-date: 1st of August 2024

Record Date: 2nd of August 2024

Date of approval: 31st of July 2024

Number of new shares: Minimum 1.125.007.508 and maximum 1.237.508.259 new shares


Subscription price: NOK 0,02

Ratio preferential rights: Each existing shareholder as of 31st of July 2024
(and being registered as such in Euronext Securities Oslo, the Norwegian Central
Securities Depository, (the VPS) as at the expiry of 2nd August 2024 (the record
date)) will be granted 2,177 subscription rights for each share registered as
held by the shareholder. The number of subscription rights granted to each
existing shareholder will be rounded down to the nearest whole subscription
right.

Subscription ratio: 1:1 (number of new shares per subscription right)

Will the rights be listed - yes/no: Yes

Manager: Sparebank 1 Markets

This information is published in accordance with the requirements of the
Continuing Obligations.

Reference is made to the notice of the extraordinary general meeting in Softox
Solutions AS announced through a stock exchange notification on 17th of July
2024 for further information regarding the rights issue.

Freely tradable subscription rights will be applied for listing on the Euronext
Growth and will be tradable from the commencement of the subscription period and
until on or about 19th of August 2024, four days prior to the expiry of the
subscription period.